Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis
NCT06306430 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2024-09-26
Summary
Evaluation of the performance of an in vitro test, the STANDARDTM F TB LAM Ag FIA (SD BIOSENSOR, INC.) for the early diagnosis of tuberculosis (TB) infection. This test is for in vitro professional diagnostic use and intended as an aid to early diagnosis of tuberculosis infection. The test will be used according to the instructions for use (IFU).
Conditions
- Tuberculosis
- Diagnoses Disease
Interventions
- DEVICE
-
STANDARDTM F TB LAM FIA
STANDARDTM F TB LAM Ag FIA is a fluorescent immunoassay for the qualitative detection of specific antigen from mycobacterial lipoarabinomannan (LAM) in urine specimen. STANDARDTM F TB LAM Ag FIA should be used with the STANDARD F Analyzers manufactured by SD BIOSENSOR.
Sponsors & Collaborators
-
Ospedale San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2024-10-31
- Completion
- 2025-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis
NCT01301144 ·Status: COMPLETED
-
Optimization of Tuberculosis Intradermal Skin Test
NCT01611844 ·Status: COMPLETED ·Phase: NA
-
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
NCT06019052 ·Status: NOT_YET_RECRUITING
-
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
NCT04666311 ·Status: COMPLETED
-
Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa
NCT01693224 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis
NCT01587677 ·Status: COMPLETED
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response
NCT03416309 ·Status: UNKNOWN
-
Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
NCT00512330 ·Status: UNKNOWN
-
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
NCT05283967 ·Status: COMPLETED
-
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
NCT03303963 ·Status: COMPLETED
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
NCT01392911 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Accuracy of New Tests for TB Infection Diagnosis
NCT06221735 ·Status: COMPLETED ·Phase: NA
-
Candidate Clinical Correlate of Prognostic Outcome for TB Study
NCT07018076 ·Status: RECRUITING
-
Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
NCT00767975 ·Status: COMPLETED ·Phase: PHASE3
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
NCT00212550 ·Status: COMPLETED
-
A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis
NCT07191834 ·Status: NOT_YET_RECRUITING
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
NCT04988984 ·Status: UNKNOWN
-
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
NCT00491933 ·Status: UNKNOWN ·Phase: NA
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
FujiLAM Prospective Evaluation Trial
NCT04089423 ·Status: COMPLETED
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
NCT00763295 ·Status: COMPLETED